Journal Articles

Angiogenesis inhibitor therapies for advanced renal cell carcinoma: Toxicity and treatment patterns in clinical practice from a global medical chart review
William K. Oh, David McDermott, Camillo Porta, Antonin Levy, Reza Elaidi, Florian Scotte, Robert Hawkins, Daniel Castellano, Joaquim Bellmunt, Sun Young Rha, Jong-Mu Sun, Paul Nathan, Bruce A. Feinberg, Jeffrey Scott, Ray McDermott, Jin-Hee Ahn, John Wagstaff, Yen-Hwa Chang, Yen-Chuan Ou, Paul Donnellan, Chao-Yuan Huang, John McCaffrey, Po-Hui Chiang, Cheng-Keng Chuang, Caroline Korves, Maureen P. Neary, Jose R. Diaz, Faisal Mehmud, Mei Sheng Duh
Pages: 5-16 Published online on: 15 November 2013

Differential prognosis of metastatic colorectal cancer patients post-progression to first-line triplet chemotherapy plus bevacizumab, FIr-B/FOx, according to second-line treatment and KRAS genotype
Gemma Bruera, Katia Cannita, Aldo Victor Giordano, Roberto Vicentini, Corrado Ficorella, Enrico Ricevuto
Pages: 17-26 Published online on: 15 November 2013

In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors
M. W. Roomi, T. Kalinovsky, M. Rath, A. Niedzwiecki
Pages: 27-34 Published online on: 31 October 2013
